نتائج البحث - "Angwin, Catherine"

1

دورية أكاديمية

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea - a MASTERMIND study protocol

المؤلفون: Angwin, Catherine, Jenkinson, Caroline, Jones, Angus, Jennison, Christopher, Henley, William, Farmer, Andrew, Sattar, Naveed, Holman, Rury R., Pearson, Ewan, Shields, Beverley, Hattersley, Andrew

العلاقة: https://bmjopen.bmj.com/content/10/12/e042784Test; Angwin, C. et al. (2020) 'TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea -a MASTERMIND study protocol', BMJ Open, 10(12), p. e042784. doi:10.1136/bmjopen-2020-042784.; https://rde.dspace-express.com/handle/11287/621836Test; BMJ Open

الإتاحة: https://doi.org/10.1136/bmjopen-2020-042784Test
https://rde.dspace-express.com/handle/11287/621836Test

View record in BASE

2

دورية أكاديمية

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

وصف الملف: text

العلاقة: http://eprints.gla.ac.uk/216838/2/216838.pdfTest; McGovern, A. P. et al. (2020) Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation. BMJ Open Diabetes Research and Care , 8(1), e001238. (doi:10.1136/bmjdrc-2020-001238 ) (PMID:32448787) (PMCID:PMC7252998)

الإتاحة: https://doi.org/10.1136/bmjdrc-2020-001238Test
http://eprints.gla.ac.uk/216838Test/
http://eprints.gla.ac.uk/216838/2/216838.pdfTest

View record in BASE

3

دورية أكاديمية

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol

المؤلفون: Angwin, Catherine, Jenkinson, Caroline, Jones, Angus, Jennison, Christopher, Henley, William, Farmer, Andrew, Sattar, Naveed, Holman, Rury R, Pearson, Ewan, Shields, Beverley, Hattersley, Andrew

وصف الملف: text

العلاقة: http://eprints.gla.ac.uk/231507/1/231507.pdfTest; Angwin, C. et al. (2020) TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. BMJ Open , 10(12), e042784. (doi:10.1136/bmjopen-2020-042784 ) (PMID:33371044) (PMCID:PMC7754630)

الإتاحة: https://doi.org/10.1136/bmjopen-2020-042784Test
http://eprints.gla.ac.uk/231507Test/
http://eprints.gla.ac.uk/231507/1/231507.pdfTest

View record in BASE

4

دورية أكاديمية

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

المؤلفون: Shields, Beverley M., Angwin, Catherine D., Shepherd, Maggie H., Britten, Nicky, Jones, Angus G., Sattar, Naveed, Holman, Rury, Pearson, Ewan R., Hattersley, Andrew T.

العلاقة: Shields, B. M., Angwin, C. D., Shepherd, M. H., Britten, N., Jones, A. G., Sattar, N. , Holman, R., Pearson, E. R. and Hattersley, A. T. (2023) Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study. Nature Medicine , 29(2), pp. 384-391. (doi:10.1038/s41591-022-02121-6 ) (PMID:36477734) (PMCID:PMC7614215)

الإتاحة: https://doi.org/10.1038/s41591-022-02121-6Test
https://eprints.gla.ac.uk/288365Test/

View record in BASE

5

دورية أكاديمية

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

المؤلفون: Shields, Beverley M., Angwin, Catherine D., Shepherd, Maggie H., Britten, Nicky, Jones, Angus G., Sattar, Naveed, Holman, Rury, Pearson, Ewan R., Hattersley, Andrew T.

المساهمون: RCUK | Medical Research Council

المصدر: Nature Medicine ; volume 29, issue 2, page 384-391 ; ISSN 1078-8956 1546-170X

مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology, General Medicine

الإتاحة: https://doi.org/10.1038/s41591-022-02121-6Test
https://www.nature.com/articles/s41591-022-02121-6.pdfTest
https://www.nature.com/articles/s41591-022-02121-6Test

View record in BASE

6

دورية أكاديمية

Crossover studies can help the individualisation of care in type 2 diabetes:the MASTERMIND approach

المؤلفون: Angwin, Catherine, Pearson, Ewan, Hattersley, Andrew

المصدر: Angwin , C , Pearson , E & Hattersley , A 2016 , ' Crossover studies can help the individualisation of care in type 2 diabetes : the MASTERMIND approach ' , Practical Diabetes , vol. 33 , no. 4 , pp. 115-117 . https://doi.org/10.1002/pdi.2015Test

مصطلحات موضوعية: /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/5f8febf9-b133-46df-9e88-3483e450843bTest

الإتاحة: https://doi.org/10.1002/pdi.2015Test
https://discovery.dundee.ac.uk/en/publications/5f8febf9-b133-46df-9e88-3483e450843bTest
https://discovery.dundee.ac.uk/ws/files/10022535/The_MASTERMIND_Approach_Practical_Diabetes_editorial_FINAL.pdfTest
http://www.scopus.com/inward/record.url?scp=84978062892&partnerID=8YFLogxKTest

View record in BASE